| UCB S.A. |
| Belgien |
| Gesundheit |
| BE0003739530 / 852738 |
| UNC (Frankfurt) |
| FRA:UNC, ETR:UNC, UNC:GR |
| - |
| https://www.ucb.com/ |
|
UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological a..
>Volltext.. |
| 47859.16 Mio. EUR |
| 47634.52 Mio. EUR |
| 7695.76 Mio. EUR |
| 2620.59 Mio. EUR |
| 1548.89 Mio. EUR |
| 8.15 EUR |
| 2231.88 Mio. EUR |
| 2237.84 Mio. EUR |
| 2150.36 Mio. EUR |
| 0.56 |
| 25.83% |
| 46.29% |
| 1.39 EUR |
| 0.39% |
| 0.39% |
| 25.04.25 - 1.39€ 26.04.24 - 1.36€ >weitere anzeigen... |
| - |
| UCB |
| 03.03.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|